We serve Chemical Name:(2S)-6-methylheptan-2-amine CAS:70419-10-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2S)-6-methylheptan-2-amine
CAS.NO:70419-10-2
Synonyms:(S)-1,5-Dimethylhexylamine;EINECS 274-598-9;(S)-2-amino-6-methyl heptane;2-Heptanamine,6-methyl-,(2S)
Molecular Formula:C7H17N
Molecular Weight:115.21700
HS Code:2921199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:155ºC at 760mmHg
Density:0.783g/cm3
Index of Refraction:
PSA:26.02000
Exact Mass:115.13600
LogP:2.47010
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (S)-1,5-Dimethylhexylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Heptanamine,6-methyl-,(2S) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Heptanamine,6-methyl-,(2S) Use and application,(S)-1,5-Dimethylhexylamine technical grade,usp/ep/jp grade.
Related News: Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. (2S)-6-methylheptan-2-amine manufacturer From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity. (2S)-6-methylheptan-2-amine supplier Pharmaceutical intermediates and APIs belong to the fine chemical industry. (2S)-6-methylheptan-2-amine vendor Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. (2S)-6-methylheptan-2-amine factory From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.
